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Abstract
We evaluated whether insulin could stimulate β-alanine uptake by skeletal muscle cells in vitro. Mouse myoblasts (C2C12) 
(n = 3 wells per condition) were cultured with β-alanine (350 or 700 µmol·L−1), with insulin (100 µU·mL−1) either added to 
the media or not. Insulin stimulated the β-alanine uptake at the lower (350 µmol·L−1) but not higher (700 µmol·L−1) β-alanine 
concentration in culture medium, indicating that transporter saturation might blunt the stimulatory effects of insulin.
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Introduction
Carnosine (β-alanyl-L-histidine) is found in the skeletal 
muscles of mammals (~ 10–40 mmol·kg−1 of dry muscle) 
(Harris et al. 2006), where it assists with pH regulation 
and antioxidant defences (Abe 2000; Carvalho et al. 2018). 
β-alanine is a constituent amino acid of carnosine and is 
found in low concentrations in skeletal muscle (~ 2 pmol/µL) 
(Goncalves et al. 2020); its low availability is rate-limiting 
for carnosine synthesis (Harris et al. 2006). β-alanine availa-
bility can be increased via meat consumption or dietary sup-
plementation. Although β-alanine supplementation increases 
skeletal muscle carnosine (Baguet et al. 2009), only ~ 6% 
of the total dose ingested contributes to this (Blancquaert 
et al. 2016). Because muscle carnosine is associated with 
improved exercise capacity (Saunders et al. 2017) and has 
potential therapeutic benefits (Artioli et al. 2019), there is 
interest in developing strategies to optimise β-alanine trans-
port into muscle cells to increase availability and enhance 
carnosine synthesis (Stegen et al. 2013). 
The ingestion of β-alanine with meals increased intra-
muscular carnosine accretion compared with the ingestion 
of β-alanine between meals (Stegen et al. (2013); this was 
attributed to a putative increase in β-alanine transporter 
activity due to hyperinsulinemia. In contrast, our group 
showed that hyperinsulinemia did not, however, increase 
β-alanine uptake into human skeletal muscle when β-alanine 
and insulin concentrations were controlled (Goncalves 
et al. 2020). Two transporters (TauT, PAT1) are involved 
in β-alanine uptake and insulin could reduce their Km or 
increase their Vmax, an effect secondary to the stimulatory 
effect of insulin on  Na+/K+/ATPase pump activity and, ulti-
mately,  Na+ influx (Clausen 2003; Sweeney and Klip 1998). 
Here, we sought to test the hypothesis that insulin can stimu-
late β-alanine uptake in skeletal muscle cells in vitro.
Materials and methods
Mouse myoblasts (C2C12, ATCC) were cultured under 
standard conditions in a humidified incubator at 37  °C 
and 5%  CO2 in high glucose (4500 mg·L−1) basal medium 
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% heat inactivated fetal bovine serum and 
100 U·mL−1 penicillin/streptomycin until confluent. The 
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medium was switched to differentiation medium (DM; high 
glucose DMEM supplemented with 2% horse serum and 100 
U·mL−1 penicillin/streptomycin) and cells were allowed to 
differentiate for 6 days. β-alanine was dissolved in DM to a 
concentration of 350 or 700 µmol·L−1. Cell culture medium 
and supplements were purchased from Sigma-Aldrich. In 
one set of experiments, insulin was added to the DM to a 
concentration of 100 µU·mL−1, while in another set, no 
insulin was added. To confirm whether the effect of insulin 
was mediated by TauT, mouse myoblasts were differenti-
ated as described above and treated with 1 mol·L−1 hypo-
taurine (a competitive TauT inhibitor) for 24 h in DM to 
inhibit β-alanine uptake. The hypotaurine was discarded, 
the cells were washed with PBS and incubated with a 
350 or 700 µmol·L−1 of β-alanine with or without insulin 
(100 µU·mL−1) in DM. Cells were incubated in these for-
mulations for 24 h. The concentration of 350 µmol·L−1 of 
β-alanine was chosen to mimic typical plasma concentra-
tions observed following the ingestion of commonly used 
β-alanine doses; the concentration of 700 µmol·L−1 was 
chosen to saturate TauT (Km ~ 40 µmol·L−1; Bakardjiev and 
Bauer 1994) and to mimic plasma concentrations elicited 
by high doses of β-alanine (Harris et al. 2006). The insulin 
concentration was chosen to mimic plasma insulin peaks fol-
lowing ingestion of a carbohydrate-rich meal (Stegen et al. 
2013). Three independent experiments per condition, each 
in triplicate were carried out.
After completion, culture medium was collected, and 
cells washed with PBS and lysed with 2 mL of 0.5% Tri-
ton X-100 in 0.2 M NaCl. One-hundred microliters of a 5% 
5-sulfosalicylic acid solution containing 500 µmol·L−1 of 
norleucine (internal standard) was added and lysate homog-
enised. After incubating for 30 min at 4 °C, the lysate was 
centrifuged at 10,000 rpm for 5 min at 4 °C, and the superna-
tant collected and filtered through a 0.22 µm centrifugal filter 
tube. Intracellular β-alanine concentrations were determined 
via high-performance liquid chromatography ion exchange 
by injecting 40 µL of the filtered supernatant through an 
automated amino acid analyser (Biochrom 30 + , Biochrom, 
Cambourne, UK). Serial dilution of amino acid standards 
(Merck, UK) with a constant internal standard concentration 
of 500 µmol·L−1 allowed for quantitation. The column was 
maintained at a 50 °C, and fluoraldehyde o-phthaldialdehyde 
was used for post-column derivatisation; the fluorescence 
detector was set at an excitation wavelength of 340 nM and 
an emission wavelength of 450 nM. The software EZ Chrom 
Elite was used to determine peak area.
Statistical analysis
Data are presented as mean ± SD with 95% confidence 
intervals (95% CI). β-alanine concentrations in cell lysates 
were compared between conditions (supplemented with 
β-alanine with or without hypotaurine and insulin, and 
non-supplemented controls) with one-way ANOVA fol-
lowed by the Tukey post-hoc where appropriate. Data 
were analysed in two data sets, those supplemented with 
350 µmol·L−1 or those with 700 µmol·L−1 of β-alanine. 
Alpha level was set at 5%. All analyses were carried out 
in the SAS statistical software (v.9.3; SAS Institute, Cary, 
NC).
Results
Cells supplemented with 350 µmol·L−1 of β‑alanine 
(Fig. 1)
Incubation with 350  µmol·L−1 of β-alanine increased 
β-alanine concentrations in cell lysates in all conditions 
(F = 339.13; p < 0.0001). Insulin further increased intracel-
lular β-alanine accrual in comparison with cells not treated 
with insulin (t = − 6.12; p = 0.002; 95% CI − 157.96 to 
− 43.93). Treatment with hypotaurine resulted in lower 
β-alanine concentrations in cell lysates in comparison with 
cells not treated with hypotaurine; this was shown either 
with (t = 21.01; p < 0.0001; 95% CI 289.77–403.80) or with-
out insulin (t = 18.37; p < 0.0001; 95% CI 246.17–360.20). 
Despite the inhibitory effect of hypotaurine on β-alanine 
uptake, insulin increased β-alanine in hypotaurine-treated 
cells (t = − 3.48; p = 0.04; 95% CI − 114.37 to − 0.34, vs. 
hypotaurine-treated without insulin).
Fig. 1  Intracellular β-alanine concentration determined in lysate of 
myoblasts treated for 24 h with DM supplemented with 350 μmol·L−1 
β-alanine with or without insulin (100 µU·mL−1) after treatment with 
hypotaurine or no treatment. Mean values measured in control cells 
are depicted by dotted lines. One-way ANOVA: all conditions are 
significantly different from control (all p < 0.0001). Tukey post-hoc: 
no insulin vs. insulin: *p = 0.002; no insulin vs. no insulin + hypotau-
rine #p < 0.001; insulin vs. insulin + hypotaurine #p < 0.001; no insu-
lin + hypotaurine vs. insulin + hypotaurine: *p = 0.04. n = 3 per condi-
tion
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Cells supplemented with 700 µmol·L−1 of β‑alanine 
(Fig. 2)
Incubation with 700 µmol·L−1 of β-alanine led to an increase 
in β-alanine concentration measured in cell lysate in all con-
ditions compared to control (F = 104.68; all p < 0.0001). 
No significant differences were shown when comparing 
β-alanine between cells treated with and without insulin 
(t = − 2.56; p = 0.17; 95% CI − 181.77 to 27.18). Treatment 
with hypotaurine resulted in lower β-alanine concentrations 
in cell lysates compared with cells not treated with hypo-
taurine; this was shown with (t = 9.13; p = 0.0001; 95% CI 
171.75–380.71) and without insulin (t = 8.92; p = 0.0001; 
95% CI 165.19–374.14). Insulin did not increase β-alanine 
concentration in cells treated with hypotaurine (t = − 2.34; 
p = 0.23; 95% CI − 175.20 to 33.75).
Discussion
β-alanine is primarily taken up into skeletal muscle cells 
in a saturable process undertaken by TauT, a  Na+ and 
 Cl− dependent transmembrane transporter driven by  Na+ 
flux, which is secondary to the action of the  Na+/K+-
ATPase pump (Jessen 1994). Since the  Na+/K+/ATPase 
pump and  Na+ influx are stimulated by insulin (Clausen 
2003), hyperinsulinemia could increase TauT efficiency 
(Stegen et al. 2013), although direct experimental evi-
dence for this is lacking. Herein, we showed that insu-
lin can stimulate β-alanine transport into skeletal mus-
cle cells, but only under lower (350 µmol·L−1) and not 
higher (700 µmol·L−1) β-alanine concentrations in culture 
medium, indicating that transporter saturation might blunt 
the stimulatory effects of insulin. The reduced β-alanine 
uptake after incubation with hypotaurine confirmed that 
β-alanine transport to skeletal muscle cells is, at least in 
part, mediated by TauT, although we acknowledge that 
hypotaurine might impact other pathways that were not 
account for in this investigation.
Stegen et al. (2013) showed that chronic β-alanine sup-
plementation in humans increased muscle carnosine con-
centration in the m. soleus, but not m. gastrocnemius, when 
β-alanine was ingested with meals (high insulin) when 
compared to between meals (low insulin). Conversely, an 
in vivo human study, using the hyperinsulinemic–euglyce-
mic clamp, showed that hyperinsulinemia did not increase 
β-alanine uptake when substrate concentrations exceeded 
the Vmax of TauT nor when it was below saturation of the 
β-alanine transporters (Goncalves et al. 2020). To further 
investigate the potential for insulin to influence β-alanine 
uptake by skeletal muscle, we used a cell culture model bet-
ter suited to specifically test this hypothesis. Under saturat-
ing conditions of β-alanine (700 μmol·L−1), no stimulatory 
effect of insulin on β-alanine uptake was shown, corroborat-
ing our earlier findings in humans (Goncalves et al. 2020) 
and supporting the notion that insulin does not increase the 
Vmax of TauT. In contrast, when myoblasts media were sup-
plemented with 350 μmol·L−1 of β-alanine, insulin induced 
greater β-alanine uptake, both under normal conditions 
and when the TauT competitive inhibitor hypotaurine was 
administered. These findings indicate that, under lower 
β-alanine concentrations, insulin potentiates β-alanine trans-
port into skeletal muscle, most likely by reducing the Km of 
TauT, resulting in its increased activity and higher affinity 
for its substrates (Richter et al. 2019). We speculate that 
this is mediated by increased  Na+ gradients, secondary to 
increased  Na+/K+/ATPase pump activity.
Although TauT is a major β-alanine transporter into mus-
cle cells (Jessen 1994), a notion that is supported by the 
dramatic decrease in β-alanine accrual in the hypotaurine-
treated cells, β-alanine can also be transported by PAT1, 
a  Na+-independent,  H+-dependent transporter (Frolund 
et al. 2010). Insulin could act upon PAT1 by stimulating the 
 Na+/H+ exchanger (Klisic et al. 2002) and, thus, one could 
argue that the higher β-alanine uptake with 350 μmol·L−1 of 
β-alanine could also have occurred via a reduced Km of the 
PAT1 transporter. However, it is known that  Na+ increases 
PAT1 activity only in acidic conditions (pH ~ 5.5–6.0) (Chen 
et al. 2003; Daniel et al. 1991), and since our experiments 
were performed within the pH range of resting skeletal mus-
cle (pH ~ 7.0), an effect of insulin on the  Na+/H+ exchanger 
is unlikely. Assuming this to be correct, there would be little 
effect on PAT1 activity, meaning that the stimulatory effect 
of insulin would be due to the increased affinity of TauT for 
β-alanine.
Fig. 2  Intracellular β-alanine concentration determined in lysates of 
myoblasts treated for 24 h with DM supplemented with 700 μmol·L−1 
β-alanine with or without insulin (100 µU·mL−1) after treatment with 
hypotaurine or no treatment. Mean values measured in control sam-
ples are depicted by dotted lines. One-way ANOVA: all conditions 
are significantly different from control (all p < 0.0001). Tukey post-
hoc: no insulin vs. no insulin + hypotaurine #p = 0.0001; insulin vs. 
insulin + hypotaurine #p = 0.0001. n = 3 per condition
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In conclusion, we demonstrate that insulin stimulates 
β-alanine uptake in skeletal muscle cells in vitro, possibly 
due to the increased affinity of TauT for β-alanine, but only 
when substrate concentration does not exceed its Vmax. More 
research is needed to determine whether this effect has rel-
evant implications for whole-body physiology.
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